SEC Comment Letter for Corbus Pharmaceuticals Holdings, Inc. (CRBP) (CIK 0001595097) (CRBP) — Jul 15, 2019

Corbus Pharmaceuticals Holdings, Inc. (CRBP) (CIK 0001595097)
Date: July 15, 2019 · CIK: 0001595097 · Accession: 0000000000-19-011115

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-37348

Date

July 15, 2019

Author

Sean M. Moran

Form

UPLOAD

Company

Corbus Pharmaceuticals Holdings, Inc. (CRBP) (CIK 0001595097)

Letter

July 15, 2019 Sean M. Moran Chief Financial Officer Corbus Pharmaceuticals Holdings, Inc. 500 River Ridge Drive Norwood, MA 02062 Re:Corbus Pharmaceuticals Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2018 Filed March 12, 2019 File No. 001-37348 Dear Mr. Moran: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text

July 15, 2019
Sean M. Moran
Chief Financial Officer
Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive
Norwood, MA 02062
Re:Corbus Pharmaceuticals Holdings, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2018
Filed March 12, 2019
File No. 001-37348
Dear Mr. Moran:
            We have completed our review of your filings.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance

SecProbe.io